A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Benitec Biopharma Inc.’s current trading price is -88.75% away from its 52-week high, while its distance from the 52-week low is 80.44%. The stock’s price range for this time frame has been between $0.13 and $2.10. The trading volume of the company’s shares in the Healthcare reached around 3.03 million for the day, which was evidently higher than the average daily volume of 0.29 million over the last three months.
Benitec Biopharma Inc. (BNTC) currently has a stock price of $0.24. The stock saw a sharp increase in the last trading session, hitting a high of $0.315 after opening at $0.22. The lowest recorded price for the day was $0.209 before it closed at $0.21.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Benitec Biopharma Inc.’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $2.10 on 06/28/22, with the lowest value being $0.13 on 10/25/22.
How Financial Performance Impacts Market Capitalization
Benitec Biopharma Inc. (BNTC) has experienced a quarterly decline of -15.61% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 6.31M and boasts a workforce of 18 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2303, with a change in price of +0.0662. Similarly, Benitec Biopharma Inc. recorded 339,350 in trading volume during the last 100 days, posting a change of +38.94%.
How BNTC’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for BNTC stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
BNTC Stock Stochastic Average
Benitec Biopharma Inc.’s raw stochastic average for the past 50 days is currently at 45.66%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 36.96%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 38.35% and 38.21%, respectively.
BNTC Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Year to date metric has recorded a gain of 38.94%.However, over the last six months, we can see a weaker performance of 31.22%. Over the last 30 days, the price of BNTC has fallen by 18.40%. And in the last five days, it has surged by 19.90%.